Kindstar Globalgene Technology, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KDGTF research report →
Companywww.kindstar.com.cn
Kindstar Globalgene Technology, Inc. provides esoteric testing services to hospitals in China. The company offers its esoteric testing services for clinical specialist physicians in hematologic tumor, rare diseases, diseases of obstetrics and gynecology, neurology, infectious diseases, solid tumors, etc.
- CEO
- Shiang Huang
- IPO
- 2021
- Employees
- 3,052
- HQ
- Wuhan, CN
Valuation
- Market Cap
- $675.13M
- P/E
- -16.73
- P/S
- 1.02
- P/B
- 0.36
- EV/EBITDA
- -10.44
- Div Yield
- 2.16%
Profitability
- Gross Margin
- 44.07%
- Op Margin
- -11.89%
- Net Margin
- -6.29%
- ROE
- -2.13%
- ROIC
- -3.44%
Performance & Tape
- 52W High
- $0.71
- 52W Low
- $0.64
- 50D MA
- $0.68
- 200D MA
- $0.68
- Beta
- 0.00
- Avg Volume
- 0
Get TickerSpark's AI analysis on KDGTF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our KDGTF Coverage
We haven't published any research on KDGTF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KDGTF Report →